BOOTHBAY FUND MANAGEMENT, LLC

Position in OVID — Ovid Therapeutics Inc.

CIK 1549230 NEW YORK, NY

Position in OVID

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,984,569

-$75,397 QoQ

Shares Held

737,758

-20.5% QoQ

Ownership

0.378%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#30

of 131 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. OVID ranks #66 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	465,787	$87,232,589
2	ABVX	Abivax S.A.	563,367	$75,074,286
3	EXEL	Exelixis, Inc.	804,095	$43,750,808
4	PCVX	Vaxcyte, Inc.	534,163	$31,050,895
5	COGT	Cogent Biosciences, Inc.	692,825	$26,812,327
6	CGEM	Cullinan Therapeutics, Inc.	1,082,611	$19,714,346
7	TNGX	Tango Therapeutics, Inc.	500,497	$15,645,536
8	AVTX	Avalo Therapeutics, Inc.	702,051	$12,973,902

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,984,569	737,758	-20.5%	Shares	Other	2026-08-14
2026-03-31	$2,059,966	927,913	+495.8%	Shares	Other	2026-05-15
2025-12-31	$253,857	155,741	-68.0%	Shares	Other	2026-02-17
2025-09-30	$632,940	486,877	+581.1%	Shares	Other	2025-11-14
2022-03-31	$224,475	71,489	0.0%	Shares	Other	2022-05-16
2021-12-31	$229,479	71,489	-36.2%	Shares	Other	2022-02-14
2021-09-30	$376,467	112,044	-20.8%	Shares	Other	2021-11-15
2021-06-30	$553,003	141,433	+7.3%	Shares	Other	2021-08-17
2021-03-31	$529,972	131,834	+125.9%	Shares	Other	2021-05-17
2020-03-31	$173,936	58,368	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.